Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients
NCT07205471 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2025-10-03
Summary
In this study,the researchers compared the changes in immune function-related indicators in patients with liver cirrhosis following laparoscopic partial splenectomy,to determine whether this surgical intervention can enhance postoperative immune function and thereby improve patient outcomes.
Conditions
- Cirrhoses, Liver
- Splenectomy; Status
- Partial
Interventions
- PROCEDURE
-
Laparoscopic Partial Splenectomy
The laparoscopic partial splenectomy technique involved preserving the short gastric vessels and the splenic suspensory ligament, with resection conducted along the demarcation line.
Sponsors & Collaborators
-
Northern Jiangsu People's Hospital
lead OTHER
Principal Investigators
-
Guo-Qing Jiang · Clinical Medical College, Yangzhou University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-24
- Primary Completion
- 2028-09-24
- Completion
- 2028-09-24
Countries
- China
Study Locations
More Related Trials
-
Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study
NCT07188220 ·Status: RECRUITING
-
Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease
NCT05107271 ·Status: COMPLETED
-
Non Alcoholic Fatty Liver Disease Influence of Statin Therapy
NCT00375349 ·Status: WITHDRAWN ·Phase: NA
-
The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis
NCT06913699 ·Status: ACTIVE_NOT_RECRUITING
-
Study in Healthy Adults Evaluating PF-07202954
NCT04857437 ·Status: COMPLETED ·Phase: PHASE1
-
Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis
NCT01220492 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis
NCT03587831 ·Status: RECRUITING ·Phase: NA
-
Expanding Donor Pool for Live Donor Liver Transplantation: Utilization of Donors With NASH After Optimization
NCT04571957 ·Status: COMPLETED
-
The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis
NCT06773221 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Influence of Diabetic Control on the Degree of Liver Fibrosis Assessed by Non-invasive Scores in Patients Followed in Diabetology
NCT05605821 ·Status: NOT_YET_RECRUITING
-
Testing a Multilevel, Culturally Appropriate Lifestyle Intervention For Hispanic Patients With Metabolic Dysfunction-associated Steatotic Liver Disease
NCT07199491 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis
NCT05065593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Digital Therapy for Fatty Liver Disease
NCT07007741 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study
NCT06078722 ·Status: UNKNOWN
-
Ambulatory Liver Fat Monitoring in Patients With Non-alcoholic Fatty Liver Disease
NCT05754385 ·Status: COMPLETED ·Phase: NA
-
Difference in Efficacy Between Stem Cell Transplantation and Classical Therapy in Liver Cirrhosis Patients
NCT01718587 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis
NCT01483248 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue
NCT05751720 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules
NCT05042245 ·Status: COMPLETED ·Phase: PHASE4
-
Nonalcoholic Steatohepatitis in Chinese Children
NCT03190538 ·Status: RECRUITING
-
Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis
NCT01728688 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Autologous Mesenchymal Stem Cell Transplantation in Liver Cirrhosis
NCT01499459 ·Status: UNKNOWN ·Phase: NA
-
To Assess the Efficacy of High-Volume Plasma Exchange and GCSF Versus GCSF Alone in Patients of Acute on Chronic Liver Failure (ACLF).
NCT03162419 ·Status: WITHDRAWN ·Phase: NA
-
Ketogenic Diet in MASLD-related cACLD
NCT06537466 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
NAFLD and Liver Fibrosis in Obese Adolescents
NCT04561804 ·Status: COMPLETED